ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies. The Company is building its activities upon the expertise of the Ludwig Cancer Research – a Research Institute in the fields of tumor immunology, therapeutic cancer vaccines, cancer biology and translational medicine in cancer.
|Employees (est.) (Jul 2021)||76||(+5%)|
ITeos Therapeutics total Funding
ITeos Therapeutics latest funding size
Time since last funding
|a year ago|
ITeos Therapeutics investors
|MPM Capital, Invus, S.R.I.W., RA Capital Management, HBM Partners, SRIW, RTW Investments, Boxer Capital, Fund+, SFPI-FPIM, 6 Dimensions Capital, Janus Henderson Investors, curative ventures, Fonds Vives II (University of Louvain, UCL), SFPI, VIVES Louvain Technology Fund, Fonds Vives II|
When was ITeos Therapeutics founded?
ITeos Therapeutics was founded in 2011.
Who are ITeos Therapeutics key executives?
ITeos Therapeutics's key executives are Michel Detheux, Joanne Jenkins Lager and Stefano Crosignani.
How many employees does ITeos Therapeutics have?
ITeos Therapeutics has 76 employees.
Who are ITeos Therapeutics competitors?
Competitors of ITeos Therapeutics include Galecto, Burning Rock Biotech and Neopharmed Gentili.
Where is ITeos Therapeutics headquarters?
ITeos Therapeutics headquarters is located at 29 Rue des Frères Wright, Charleroi.
Where are ITeos Therapeutics offices?
ITeos Therapeutics has offices in Charleroi and Cambridge.
How many offices does ITeos Therapeutics have?
ITeos Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies